Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 91
Selected: 0
NCT IDTitle
NCT00821717EFfect of Ferric Carboxymaltose on exercIse CApacity and Cardiac Function in Patients With Iron deficiencY and Chronic Heart Failure
NCT02033317An Open-Label, Multiple Dose Study to Evaluate the Pharmacology, Safety, and Tolerability of Patiromer in Participants on Hemodialysis
NCT01464190A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients
NCT02232906Switch From Oral Iron to Intravenous Ferric Carboxymaltose in Non-dialysis Chronic Kidney Disease (CKD)
NCT03047954Broncho-Vaxom (OM 85 BV) in Children Suffering From Atopic Dermatitis
NCT04616092Effect of Preoperative Intravenous Ferric Carboxymaltose for Clipping Surgery
NCT02557477Omega 3/6 Fatty Acids for Reading in Children
NCT01324128A Phase 3 Study to Investigate the Safety and Efficacy of PA21, a Phosphate Binder, in Dialysis Patients
NCT01288651Iron Deficiency In Pulmonary Hypertension
NCT01101399Ferric Carboxymaltose in Subjects With Functional Iron Deficiency Undergoing Chemotherapy
NCT01477411A Drug-Drug Interaction Study of Digoxin and PA21
NCT01975272The Use of Iron Therapy for Patients With Anemia After Caesarean Section
NCT00746551Intravenous Versus Oral Iron in Late Pregnancy: Results of Treatment
NCT05077436Bioavailability Study Comparing 2 Vamifeport Oral Formulations in Fasted Versus Fed State in Healthy Subjects
NCT05524467Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Haemodialysis Patients
NCT05625542Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Hemodialysis Patients
NCT05751772Improving Knowledge in Heart Failure Inpatient With Therapeutic Education
NCT04817670Study to Assess Efficacy and Safety of VIT-2763 (Vamifeport) in Subjects With Sickle Cell Disease
NCT00824460Study of Phosphate Levels in Patients With Chronic Kidney Disease
NCT04806048Feasibility of Implementation of Recommended Standards in Patients With Heart Failure
NCT01452906A Drug-Drug Interaction Study of Omeprazole and PA21
NCT05460234RAYALDEE Non Interventional Study (NIS) on Effectiveness in ND-CKD SHPT Patients
NCT00994318Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
NCT02125344A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)
NCT05415969CKD-aP Among Adults on Dialysis in Switzerland
NCT06434025IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency
NCT01477424A Drug-Drug Interaction Study of Warfarin and PA21
NCT06593392Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus
NCT01453608A Study to Compare the Use of Ferric Carboxymaltose With Placebo in Patients With Chronic Heart Failure and Iron Deficiency
NCT05136664Trial Evaluating the Efficacy and Safety of Patiromer in Chinese Subjects
NCT01219309Omega-3/Omega-6 Fatty Acids for Attention-Deficit/Hyperactivity Disorder (ADHD): A Trial in Children and Adolescents
NCT01438359A Drug-Drug Interaction Study of Furosemide and PA21
NCT03574311Preoperative Intravenous Ferric Carboxymaltose and Placebo in the Treatment of Patients Undergoing Cardiac Surgery
NCT05389826mHealth for Phosphorus Management in CKD.
NCT03591406To Assess the Impact of Ferric Carboxymaltose Compared With Iron Sucrose in Chinese Subjects on Correcting Iron Deficiency Anaemia
NCT00520780Ferinject® Assessment in Patients With Iron Deficiency and Chronic Heart Failure (FAIR-HF)
NCT02937454Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron Deficiency
NCT02213653Randomized Study Evaluating Agents Stimulants Erythropoiesis (ASE) Associated With Ferric Carboxymaltose (Ferinject ®) in Concomitant or Sequential Patients Treated for Cancer and With Anemia Associated With Functional Iron Deficiency
NCT02694744Patiromer With or Without Food for the Treatment of Hyperkalemia
NCT00810004Maintenance Treatment of Iron Deficiency in IBD Patients
NCT03957187Prevalence and Clinical Associates of Iron Deficiency in Patients With Atrial Fibrillation
NCT01324752A Drug-Drug Interaction Study of Losartan and PA21
NCT01057004EVIdence Based TreAtment - Heart Failure (EVITA-HF)
NCT04364269Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Preliminary Efficacy of VIT-2763 in β-thalassaemia
NCT03644264PA21 Safety and Efficacy in Adult Chinese Subjects
NCT03759964Effects of Ferinject® on Anemia and Transfusion Rates After Cardiac Surgery
NCT04864795Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalaemia or at High Risk of Hyperkalaemia
NCT01513369Ferric Carboxymaltose in Type 2 Diabetes Mellitus (T2DM) Patients With Iron Deficiency
NCT02846896The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland
NCT05861492FDDA Utilization Study (FDDAU)